Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) (351108)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website Save this grant

Next deadline: Jun 17, 2024

Later deadlines: Jul 16, 2024, Oct 16, 2024, Nov 18, 2024, Feb 17, 2025, Mar 17, 2025, Jun 16, 2025, Jul 16, 2025, Oct 16, 2025, Nov 17, 2025, Feb 16, 2026, Mar 16, 2026, Jun 16, 2026, Jul 16, 2026, Oct 16, 2026, Nov 16, 2026

Grant amount: Up to US $1,850,000

Fields of work: Alcoholism Maternal And Perinatal Health

Applicant type: Nonprofit, Government Entity, Indigenous Group, For-Profit Business

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: The following deadlines apply to standard grant applications (due by 5:00 pm  local time of applicant organization). Optional but encouraged Letters of Intent are due thirty days prior to application due date.


  • February 16, 2024
  • June 17, 2024
  • October 16, 2024
  • February 17, 2025
  • June 16, 2025
  • October 16, 2025
  • February 16, 2026
  • June 16, 2026
  • October 16, 2026
The following deadlines apply to Renewal/Resubmission/Revision grant applications (due by 5:00 pm local time of applicant organization). Optional but encouraged Letters of Intent are due thirty days prior to application due date..

  • March 18, 2024
  • July 16, 2024
  • November 18, 2024
  • March 17, 2025
  • July 16 , 2025
  • November 17, 2025
  • March 16, 2026
  • July 16, 2026
  • November 16, 2026
This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances  prevention approaches to reduce prenatal alcohol exposure and the incidence of FASD and that interventions for FASD. These objectives will be accomplished with the Exploratory/Developmental Phased Award (R61/R33) mechanism, clinical trial optional. The R61 phase will support pilot studies or secondary data analysis for hypothesis development and feasibility, and research testing the hypotheses can be expanded in the R33 phase. The transition to the R33 phase will be determined by NIAAA program staff after evaluation of the achievement of specific milestones set for the R61 phase. Highest priority will be given to applications with clinical trials. Applicants interested in planning clinical trials or adding to current projects may also consider NOFO (TEMP-23832, the R34 option).

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

US Dept. of Health & Human Services: National Institutes of Health (NIH)
FUNDER

Your history with this funder
0
SAVED OPPORTUNITIES
No saved opportunities from this funder yet
FUNDER NOTES
Save this opportunity to add notes...
CONTACTS
Save this opportunity to add contacts...

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

Forecasted Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih) help icon

Find funders like US Dept. of Health & Human Services: National Institutes of Health (NIH)

See funders proven to support nonprofits like yours.

No credit card required.
instrumentl testimonial face

"Winning 30% more grants thanks to Instrumentl was a huge morale boost. My confidence continues to grow."

Linda Rucker, Grant Writer

This page was last reviewed November 29, 2023 and last updated November 29, 2023